A carregar...

Application of Biomarkers to Clinical Trials in Systemic Sclerosis

Important clinical advances in the treatment of systemic sclerosis have been made, yet fibrotic disease remains largely untreatable. Optimal design of clinical trials to test new therapeutics for fibrotic disease features has suffered from dual difficulties in patient selection and patient evaluatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Lafyatis, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3261634/
https://ncbi.nlm.nih.gov/pubmed/22052444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-011-0216-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!